Английская Википедия:AKS-452

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Infobox drug Шаблон:COVID-19 pandemic sidebar AKS-452 is a COVID-19 vaccine candidate developed by Akston Biosciences.[1][2]

References

Шаблон:Reflist

Шаблон:Scholia

Шаблон:Vaccines Шаблон:COVID-19 pandemic Шаблон:Portal bar


Шаблон:COVID19-vaccine-stub Шаблон:Vaccine-stub

  1. {{#invoke:Cite web| |title=Anti-COVID19 AKS-452 – ACT Study (ACT) |url=https://clinicaltrials.gov/ct2/show/NCT04681092 |website=ClinicalTrials.gov |date=23 December 2020 |id=NCT04681092 |access-date=21 March 2021 }}
  2. {{#invoke:Cite web| |title=A study to assess the safety and immunogenicity of Anti-COVID-19 AKS-452 vaccine for SARS-Сov-2 infection in Indian healthy subjects. |url=http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=59540&EncHid=&userName=covid-19%20vaccine |website=ctri.nic.in |date=11 October 2021 |id=CTRI/2021/10/037269 |access-date=11 October 2021 }}